



(http://creativecommons.oFlexible Stoichiometry and Asymmetry of the
PIDDosome Core Complex by Heteronuclear
NMR Spectroscopy and Mass Spectrometryllahi 1, Acely Garza-Garcia 1, Chérine Bechara2, Diego Esposito1,
Nina Morgner , Carol V. Robinson2 and Paul C. Driscoll 1
1 - Division of Molecular Structure, Medical Research Council, National Institute for Medical Research, The Ridgeway, Mill Hill,
London NW7 1AA, UK
2 - Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, Oxford OX1 3QZ, UKCorrespondence to Paul C. Driscoll: pdrisco@nimr.mrc.ac.uk
http://dx.doi.org/10.1016/j.jmb.2014.11.021
Edited by R. W. KriwackiLegend. Non-equiva
(gray) among the pse
in the PIDDosome co




features in the spectr
Authors. Published by Elsevier Ltd. This is an open acce
rg/licenses/by/3.0/).Lily A. Nematollahi and Paul C. Driscolllence of methyl-group side chains
udoequivalent interdomain contacts
re crystal structure (PDB code 2OF5
tribution of the transverse relaxation
opy nuclear magnetic resonance
s a single feature for the isolated
(DD) (black contours) into multiple
um of the complex (red contours).
ss article under the CC BY licens
J. Mol. Biol. (2015) 427, 737–75)Abstract
Homotypic death domain (DD)–DD interactions are
important in the assembly of oligomeric signaling
complexes such as the PIDDosome that acts as a
platform for activation of caspase-2-dependent
apoptotic signaling. The structure of the PIDDosome
core complex exhibits an asymmetric three-layered
arrangement containing five PIDD-DDs in one layer,
five RAIDD-DDs in a second layer and an additional
two RAIDD-DDs. We addressed complex formation
between PIDD-DD and RAIDD-DD in solution using
heteronuclear nuclear magnetic resonance (NMR)
spectroscopy, nanoflow electrospray ionization
mass spectrometry and size-exclusion chromatog-
raphy with multi-angle light scattering. The DDs
assemble into complexes displaying molecular
masses in the range 130–158 kDa and RAIDD-DD:
PIDD-DD stoichiometries of 5:5, 6:5 and 7:5. These
data suggest that the crystal structure is represen-
tative of only the heaviest species in solution and
that two RAIDD-DDs are loosely attached to the 5:5
core. Two-dimensional 1H,15N-NMR experiments
exhibited signal loss upon complexation consistent
with the formation of high-molecular-weight species.
13C-Methyl-transverse relaxation optimized spec-
troscopy measurements of the PIDDosome core
exhibit signs of differential line broadening, cross-peak
splitting and chemical shift heterogeneity that reflect
the presence of non-equivalent sites at interfaces
within an asymmetric complex. Experiments using ae
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738 Asymmetry of the PIDDosome Core Complexmutant RAIDD-DD that forms amonodisperse 5:5 complex with PIDD-DD show that the spectroscopic signature
derives from the quasi- but non-exact equivalent environments of each DD. Since this characteristic was
previously demonstrated for the complex between the DDs of CD95 and FADD, the NMR data for this system are
consistent with the formation of a structure homologous to the PIDDosome core.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
The PIDDosome is a high-molecular-weight cyto-
solic complex that is formed as a response to DNA
damage or cellular stress containing three proteins:
p53-induced DD protein (PIDD), receptor-interacting
protein-associated Ich-1/CED homologous protein
withDD (RAIDD) and the cysteine protease caspase-2
[1–3]. ThePIDDosome acts as a platform for activation
of caspase-2 and triggering of the mitochondrial
apoptotic pathway [4–6]. PIDD contains seven leuci-
ne-rich repeats at the N-terminus; two ZO-1 and
Unc5-like (ZU-5) domains; an uncharacterized protein
domain in Unc5, PIDD and ankyrin family of proteins
(UPA) domain; and aDD (PIDD-DD) at the C-terminus
(Fig. 1a) [7,8]. PIDD undergoes autocleavage in an
intein-like mode to yield fragments of differing molec-
ular masses: cleavage at Ser446 in the linker between
the ZU-5 domains yields PIDD-N (residues 1–445,
48 kDa) and PIDD-C (residues 446–910, 51 kDa);
further cleavage of PIDD-C at Ser588 in the linker
between the second ZU-5 domain and the DD yields
PIDD-CC (residues 588–910, 37 kDa) [7,9,10].
PIDD-C can form a complex with receptor-interacting
protein 1 andNF-κBessential modulator, leading to the
activation of the transcription factor NF-κB. The
PIDD-CC fragment is required for the RAIDD-depen-
dent activation of caspase-2. RAIDD therefore acts as
an adaptor protein between PIDD-CC and caspase-2,
comprising an N-terminal caspase recruitment domain
(CARD) tethered to a C-terminal DD (RAIDD-DD)
(Fig. 1b) [2]. Caspase-2, the enzymatic component of
the PIDDosome complex, possesses an extended
N-terminal CARD domain and a C-terminal protease
domain composed of large (p19) and small (p12)
subunits [11,12]. It is reported that the expression of just
the PIDD-DD is sufficient to sensitize colon carcinoma
cells to UV-induced apoptosis [10] and to induce
formation of a complex with RAIDD and caspase-2 in
293T cells [9]. Homotypic interaction between the DDs
of PIDD and RAIDD and CARDs of RAIDD and
caspase-2 leads to the formation of the PIDDosome
that brings caspase-2molecules into proximity, thereby
facilitating dimerization and caspase activation [13].
Caspase-2 permeabilizes the outer mitochondrial
membrane resulting in the release of cytochrome c
and Smac/DIABLO and subsequent activation of
executioner caspase-3 and caspase-9 [14]. That
PIDD is implicated in both pro-survival (NF-κB) andcell death mechanisms means that it has been labeled
as a “switch hitter” [7,15,16] with a potentially complex
mode of regulation. For example, it has been
suggested that interaction of PIDD with RAIDD and
subsequent caspase-2 activation is facilitated by
phosphorylation of Thr788, a residue adjacent to
the DD [1]. One possibility is that phosphorylation of
PIDD Thr788 relieves intramolecular inhibition of the
RAIDD-binding potential of PIDD-DD in the full-length
protein.
In vitro reconstitution of the core of the PIDDosome
complex has been demonstrated using the isolated
DDs of PIDD and RAIDD [2,3,17]. The 3.2-Å-resolu-
tion crystal structure (PDB code 2OF5) was obtained
for a complex formed between the two DDs at pH 6.5
[2]. The structure revealed a high-molecular-weight
particle containing five PIDD-DDs and seven
RAIDD-DDs arranged in three layers (Fig. 2). Five
PIDD-DD chains occupy a bottom layer that sits
underneath a second layer of five RAIDD-DDs; two
additional RAIDD-DDs sit on top of these five
RAIDD-DDs in a third layer (Fig. 2b). The overall
structure is formally asymmetric, lacking any mirror
planes. In the structure, each DD has between three
and six immediate neighbors. The eight different
examples of interdomain interface have been catego-
rized into three classes, known as types I, II and III
based on the regions of the DD structure that are
involved in each contact [2,18–20]. The whole arrange-
ment of theDDswithin the structure canbe represented
schematically as shown in Fig. 2c.
The crystal structure of the PIDDosome core
appears to accurately represent the species present
in solution. Prediction of the electron microscopy
projections from the structure provides images that
closely match those observed experimentally [2].
Moreover, the 150-kDamolecular mass of the particle
predicted from the crystal structure is in line with
estimates based on solution measurements using
size-exclusion chromatography (SEC) coupled with
multi-angle light scattering (MALS) [2]. Curiously,
however, themolecularmasswas separately reported
as 103 kDa when assessed by sedimentation equi-
librium analytical ultracentrifugation [3,17]. Although
the PIDDosome core crystal structure has provided
useful information about the interactions and inter-
faces involved in the formation of the complex, the
unusual 7:5 stoichiometry, the absence of formal
symmetry and the inconsistent reports of the
739Asymmetry of the PIDDosome Core Complexmolecular mass reflect that questions remain con-
cerning the properties of the particle in solution.
Transverse relaxation optimized spectroscopy
(TROSY) methods represent a means to probe the
nature of high-molecular-weight species in solution.
In particular, 13C-methyl-group TROSY experiments
enable the characterization of the environments of
methyl groups in arbitrarily large macromolecular
assemblies, for example, see Refs. [21–28]. These
experiments exploit the effects of cross-correlation
of dipolar 1H-1H and 1H-13C interactions within
isolated 1H3
13C-methyl groups that lead to a compo-
nent of the magnetization that relaxes slowly and
hence leads to relatively sharp cross-peaks. The
application of 13C-methyl-TROSY requires that the
methyl 13C atom is bonded to a 12C atom and that
vicinal protons, in particular, are replaced with deu-
terons, so as to eliminate deleterious scalar and dipolar
coupling interactions. Typically, the required isotope-
labeling pattern is obtained by culturing the expression
strain of bacteria in a D2O/glucose-based minimal
medium that contains a perdeuterated carbon source
and appropriately labeled amino acid precursor mole-
cules. Incorporation of methyl-13C-3,3-d2-ketobutyric
acid leads to 1H3,
13Cδ1-methyl-d10-isoleucine
whereas 3-methyl-13C-3,4,4,4-d4-ketoisovaleric acid
leads to both 1H3,
13C γ-methyl-d8-valine and
1H3,
13Cδ-methyl-d10-leucine, wherein only one of the
two prochiral methyl groups is 1H3,
13Cγ-labeled. For
brevity, protein samples prepared using a combination
of these precursors are referred to as ILV-labeled.
Although the ILV-labeling technique has beenwidely
used to study isotope-labeled proteins within symmet-
ric homomeric or heteromeric particles [25,29–36],
examples of its application to asymmetric multimers
have been extremely limited. We have previously
applied 13C-methyl-TROSY nuclear magnetic reso-
nance (NMR) to particles assembled by the DDs of the
tumor necrosis superfamily receptor CD95/Fas and its
adaptor protein FADD [33]. The spectra of the
complexes obtained contained many more cross-
peaks than were present for the isolated components,
leading us to speculate that the particles either were
highly heterogeneous in character ormight lack formal
symmetry, or possibly both.Fig. 1. Schematic representation of the domain structure
boundaries indicated in numerals. For PIDD, the gray tria
autocleavage leads to C-terminal fragments of the protein.Here we revisit the structure and composition of the
PIDDosome core complex in solution. We establish
that the crystal structure is representative of the
heaviest PIDDosome core complex species present
in solution. A mutation designed to selectively disrupt
the type II RAIDD-DD:RAIDD-DD interface leads to
the formation of a more uniformly disperse 5:5
subcomplex. We have also applied ILV labeling and
13C-methyl-TROSY to the PIDDosome core particle.
Remarkably, after controlling for the potential for
compositional heterogeneity, we find that the NMR
spectra clearly reflect the asymmetry anticipated from
the crystal structure, arguing that the complexity of the
quaternary structure is not a result of crystal lattice
forces. Moreover, the data indicate that exchange
between subsites in the PIDDosome core particle is
slow on the chemical shift timescale. The observations
bolster the interpretation of the previously recorded
13C-methyl-TROSY spectra for the CD95/FADD DD
assembly in terms of an asymmetric structure rather
than compositional heterogeneity [33], as well as
reinforce the conclusion that the structure of that
particle resembles that of the PIDDosome core [37].
Results
The PIDDosome core complex shows flexible
stoichiometry in solution and gas phases
There are conflicting reports concerning the molec-
ular mass and stoichiometry of the PIDDosome
particle [2,3,17]. We analyzed the molecular mass of
the complex formed by RAIDD-DD with PIDD-DD
using both analytical SEC coupled to MALS and
nanoflow electrospray ionization (nanoESI) mass
spectrometry (MS) (Fig. 3a).
SEC-MALS samples were run over a total protein
concentration range of 1.5–24 mg/mL. The symmetric
chromatographic light-scattering profile was consis-
tent with a monodisperse particle with elution volume
12.4 mL in the range 6–24 mg/mL. The elution
volume was slightly larger (12.6 mL) at 1.5 mg/mL,
suggesting some subunit dissociation at the lowest
concentration tested. There was no significant(a) PIDD and (b) RAIDD proteins, with predicted domain
ngles indicate the points at which intein-like proteolytic
Fig. 2. The crystal structure of the PIDDosome complex formed between PIDD-DD and RAIDD-DD (PDB ID 2OF5).
Magenta and blue colors are used to depict the RAIDD-DD domains; red, the PIDD-DD domains. (a) Backbone secondary
structure of isolated RAIDD-DD and PIDD-DD chains. (b) Overall PIDDosome structure arranged to highlight the bottom
layer of five PIDD-DDs, the “middle” layer of five RAIDD-DDs and the top two RAIDD-DDs R6 and R7. (c) A schematic
summary of the domain–domain interactions present within the PIDDosome core structure, adapted from Ref. [2]. The
broken lines indicate the extent of the core structure, with domains P4, R4 (left-hand side) and P5, R5 and R6 (right-hand
side) depicted a second time in lighter hues to represent the axis of pseudohelical symmetry, suggested by the green arrow
in (b). Each domain occupies a pseudosimilar position in the structure, defined by the types I–III interdomain contacts [19]
respectively indicated by a thick black bar, two parallel lines and three parallel lines. The angular rotation and translational
rise and fall reflecting the domain-to-domain packing of the structure are depicted by arrows at the top of the schematic.
740 Asymmetry of the PIDDosome Core Complexreadout at elution volumes greater than 13 mL other
than that of a small amount of excess free DD at
17.5 mL (data not shown), indicating the absence of
any population corresponding to intermediate species
and suggesting a considerable degreeof cooperativity
in complex formation.
Analysis of the fractions of analytical gel-filtration
experiments by SDS-PAGE revealed that the eluted
complexes contained approximately equal amounts
of the two component DDs (data not shown). The
SEC-MALS data indicate that the two DDs form a
complex with a maximum molecular mass of
~120 kDa. Taking into consideration the predicted
molecular masses of the individual domains
(PIDD-DD, 13.4 kDa; RAIDD-DD, 13.0 kDa), these
results suggest the formation of a particle containing
at least nine protein chains. Decreasing the total
protein concentration resulted in a reduction in theaverage molecular mass to 93 kDa (corresponding
to a total of seven DD chains).
Purified PIDDosome core complexes were ana-
lyzed by nanoESI-MS using procedures designed to
maintain non-covalent interactions in complexes [38].
The measurements provide a snapshot of the profile
of molecular masses and subunit composition of
macromolecular assemblies present in the sample.
The mass spectrum obtained shows signals for high
m/z ion series attributable to the PIDDosome core
particles. There were three main overlapping charge
series of ions. These series represent complexes
with an overall mass of 132.0 kDa, 145.1 kDa and
158.1 kDa corresponding to 5:5, 6:5 and 7:5 stoichi-
ometry, respectively, based on internal mass reference
for the isolated RAIDD-DD and PIDD-DD monomers
(Fig. 3b). The population distributions of the three
complexeswere 28%, 43%and 29%, respectively, and
Fig. 3. Assessment of the molecular mass of the wild-type RAIDD-DD:PIDD-DD complexes in solution by (a)
SEC-MALS and (b) nanoESI-MS. In (a), the overall protein loading concentration was 1.5 mg/mL (magenta), 12 mg/mL
(blue) and 24 mg/mL (red). In (b), native mass spectrum of 15 μM complex in 50 mM ammonium acetate buffer (pH 7.8)
and ion series corresponding to RAIDD-DD:PIDD-DD species with stoichiometries 5:5, 6:5 and 7:5 are labeled with their
charge states and indicated with blue circles, orange squares and purple triangles, respectively.
741Asymmetry of the PIDDosome Core Complexthe recoveredmolecular masses were within 3% of the
predicted values based on the amino acid sequence.
There were also some minor peaks in the spectrum
corresponding to higher-molecular-weight species that
might be due to non-specific binding of higher order.
Importantly, ion series corresponding to assemblies
with molecular mass lower than 132 kDa were not
observed.
The PIDDosome core complex is mainly invisible
to 15N-HSQC experiments as expected for a
high-molecular-weight particle
We separately titrated 15N-labeled PIDD-DD, as
well as 15N-labeled RAIDD-DD with the respective
unlabeled binding partner, and recorded series of
two-dimensional (2D) 15N,1H-heteronuclear single
quantum coherence (HSQC) NMR spectra using the
method reported previously [33] (Fig. 4). In all cases,
as the concentration of the unlabeled binding partner
is increased, the majority of the cross-peaks in the
spectrum showed significant reduction in their
intensity, ultimately to a level below the noise.
Throughout the titration, there is no evidence of
chemical shift perturbation of the cross-peaks. Only
a small subset of cross-peaks remains at the end of
the titration. Sequence-specific resonance assign-
ments were used to confirm that the persistentcross-peaks belong to the protein backbone amide
NH groups or side-chain NH2 groups of Asn, Gln or
Arg residues from the extreme N- and C-terminal
regions of each domain type. Thus, the backbone
amide cross-peaks of residues Asp781 and Ala884
at the N- and C-terminus, respectively, of PIDD-DD
(Fig. 4b) and the backbone amide cross-peaks of
Thr95–Asp101 in the N-terminus and a backbone
amide NH from the hexahistidine affinity tag in the
C-terminus of RAIDD-DD (Fig. 4d) remain visible at
the end of the titration.
ILV-labeling and TROSY-based NMR experiments
show complex formation between PIDD-DD
and RAIDD-DD
We analyzed complex formation between PIDD-DD
and RAIDD-DD using 1H,13C-methyl-group labeling
for Ile, Leu and Val side chains in perdeuterated
ILV-labeled samples [34] and 13C-methyl-TROSY
NMR [39].Weseparately prepared ILV-13CH3-labeled
perdeuterated samples of RAIDD-DD and PIDD-DD.
The corresponding 13C-methyl-TROSY spectra are
presented in Fig. 5. In each case, the cross-peaks in
the free-state spectra are well resolved and display
chemical shift dispersion typical for a small globular
protein. Addition of a perdeuterated sample of the
respective DD binding partner dramatically changed
Fig. 4. NMR evidence for high-molecular-weight PIDDosome complex formation. Two-dimensional 15N-heteronuclear
NMR spectra of isolated 15N-labeled RAIDD-DD (a) and 15N-PIDD-DD (c) and the corresponding complexes formed with
excess unlabeled PIDD-DD (b) and RAIDD-DD (d), respectively. For the complexes, only a small number of cross-peaks
are detected, and resonance assignment of these signals indicates that they originate from the extreme N- and C-termini of
PIDD-DD and RAIDD-DD in each case.
742 Asymmetry of the PIDDosome Core Complexthe appearance of the spectrum. When the unlabeled
protein is added to ILV-13CH3-labeled binding partner,
the intensity of the methyl-group cross-peaks is
significantly reduced due to the complex formation.
However, the effects on the cross-peaks can be
divided into two characteristically distinguishable
types. First, a small subset of cross-peaks retains
their narrow line shape, with relatively high peak
intensity, and either unperturbed or only slightly
perturbed chemical shifts relative to those for the
unbound protein. This subset of cross-peaks, which
are only marginally broader in the spectrum of the
complex compared to the free-state spectrum, can
readily be identified by plotting the spectrum at a
relatively high base contour level. Specific reso-
nance assignment of these cross-peaks showed
that they can be attributed to the ILV residues
residing in the flexible N- and C-terminal regions of
the labeled protein. For example, the methyl-group
cross-peaks corresponding to Ile106, Ile110,
Leu103 and Leu97 in ILV-labeled RAIDD-DD are
members of this subset and correspond to residues
in the flexible N-terminus. Similarly, a methyl-group
cross-peak for Leu200 that resides in the vector-encoded C-terminal affinity tag in RAIDD-DD is also
in this group (Fig. 5a). Correspondingly, the
methyl-group cross-peaks for Leu779 and Leu875,
respectively arising from the flexible N- and C-termini
of PIDD-DD, show essentially identical character-
istics in the presence of perdeuterated RAIDD-DD
(Fig. 5b).
The remaining ILV-methyl-group cross-peaks are
only visible at much lower contour levels. As
exemplified in Fig. 6, these cross-peaks show a
distinctly different dependence upon the presence of
the binding partner protein. Namely, it appears that
each cross-peak in the free-state spectrum splits into
a cluster of either resolved or partially overlapping
cross-peaks in the spectrum of the complex. The
total intensity of each starting “singlet” cross-peak is
apparently dispersed among the multiple members
of the resultant clusters. The complexity of the
spectrum is dramatically increased as a result of
the increased cross-peak multiplicity particularly in
the middle of the spectrum (Fig. 6a), making
identification of the link between parent “singlet”
and daughter cluster components ambiguous. The
precise nature of the effect of complex formation on
Fig. 5. Methyl-TROSY NMR spectra for PIDDosome formation. Two-dimensional 13C-methyl-TROSY NMR spectra
of ILV-13CH3-labeled RAIDD-DD (a) and PIDD-DD in the presence (red) and absence (black) of excess unlabeled
PIDD-DD and RAIDD-DD, respectively, plotted at high contour threshold. A subset of the assignments of cross-peaks that
remain visible in the complexed state is indicated in each case.
743Asymmetry of the PIDDosome Core Complexthe 13C-methyl-TROSY spectrum is most readily
understood by examining the fates of the most highly
resolved features in the free-state spectrum. For
instance, the “singlet” cross-peaks for Ile820-Cδ1H3
and Ile832-Cδ1H3 in ILV-labeled PIDD-DD (Fig. 6b)
and Val180-Cγ1H3 and Val195-C
γ2H3 in ILV-labeled
RAIDD-DD (Fig. 6c) are each converted into a
cluster of at least four separate cross-peaks, with
differing intensity, in the spectrum of the correspond-
ing complex.Fig. 6. Cross-peak clusters are formed for many methyl gro
13C-methyl-TROSY NMR spectra of ILV-13CH3-labeled RAIDD
absence (black) of excess unlabeled PIDD-DD and RAIDD-DD
clusters of low-intensity cross-peaks associated with PID
cross-peaks in the unbound state are indicated.The splitting of the methyl-group cross-peaks into
clusters in the presence of the binding partner must
result from the formation of one or more structures in
which the environment of individual component mole-
cules is non-equivalent. Such an outcome could arise
from the formation of a single asymmetric structure or
potentially from the presence of multiple complexes
with different composition. In principle, both scenarios
might apply together; that is, sample contains different
complexes each with a different symmetry.ups upon PIDDosome formation. Selected regions of the
-DD (a and c) and PIDD-DD (b) in the presence (red) and
, respectively, plotted at low contour threshold to reveal the
Dosome formation. Methyl-group assignments of the
Fig. 7. Analysis of interdomain contacts within the
PIDDosome core crystal structure. (a) Close-up of the
involvement of Glu188 in the type II contact between
RAIDD-DD domains R5 and R6. The chains are colored
according to the scheme in Fig. 2. Broken lines indicate
predicted hydrogen bond interactions. (b) Schematic
representation of the position of selected side chains
within the PIDDosome crystal structure. Note that Glu188
is only involved in interdomain contacts for RAIDD-DD
chains R2 and R5; for R1, R3-R4 and R6-R7, the Glu188
side chain is directed into solvent.
744 Asymmetry of the PIDDosome Core ComplexDesign of a monodisperse 5:5 PIDDosome
complex
We anticipated that the PIDDosome core complex
formed in solution might possess similar character-
istics to that visualized in the crystal structure [2] and
therefore be intrinsically asymmetric. However, our
SEC-MALS and MS data indicated that the sample
contained a mixture of species with sizes up to and
including the particle with 7:5 RAIDD-DD:PIDD-DD
composition that is present in the crystals. We
sought to use the crystal structure as a guide to
develop a more homogeneous variant of the
complex. We noted that the B-factors of the two
“apical” RAIDD-DD domains in the crystal structure,denoted R6 and R7, are systematically much higher
than those for theother 10 chains in the complex (mean
B-factors for RAIDD-DD domains R1-R7, respectively:
116, 110, 96, 101, 111, 177 and 197 Å2; mean
B-factors for PIDD-DD domains P1-P5, respectively:
101, 116, 94, 92 and 115 Å2). We hypothesized that
these two domains might be less stably associated
with the remainder of the particle and that loss of these
two domains might be linked to the observation of ion
series corresponding to RAIDD-DD:PIDD-DD compo-
sitions of 6:5 and 5:5 in the MS data. Careful analysis
of the type II RAIDD:RAIDD interfaces that mediate
the attachment of theR6andR7RAIDD-DDmolecules
to the rest of the structure suggested that selective
disruption of these contacts might be achievable
through targeted site-directed mutagenesis (Fig. 7a).
Specifically, we identified that, of the residues that
contribute to the type II R:R interface, only Glu188 is
not involved in other RAIDD-DD:RAIDD-DD or
RAIDD-DD:PIDD-DD contacts (Fig. 7b). For example,
the relative solvent-accessible area for theGlu188 side
chain in the RAIDD-DD polypeptides R1 through R7 is
99%, 54%, 99%, 88%, 56%, 104% and 103%,
respectively. The low values of the accessible surface
area for this residue in chainsR2 andR5are consistent
with their involvement in type II contacts with chainsR6
and R7, respectively. We concluded that variation of
the side chain at the Glu188 position had the potential
to selectively modify the strength of interaction of R6
and R7 domains in the PIDDosome core. We mutated
RAIDD-DD Glu188 to Lys. The RAIDD-DD (E188K)
protein was expressed and purified as a stable,
folded protein. The 15N,1H-HSQC spectrum of the
RAIDD-DD (E188K) shows very few differences
compared to the wild type, consistent with the highly
exposed nature of this residue in the free protein (data
not shown; see also Fig. 9a and b). We then formed a
“mutant” complex of RAIDD-DD (E188K) with
PIDD-DD and analyzed the samples as for the
wild-type situation.
We assessed the molecular mass of the mutant
complex by both SEC-MALS and nanoESI-MS.
SEC-MALS samples were run over a total protein
concentration range of 1.5–24 mg/mL. The symmet-
ric chromatographic light-scattering profile was very
similar to the one obtained for the PIDDosome core
complex (Fig. 8a). The analysis of the SEC-MALS
data over a concentration range of 12–24 mg/mL
yielded an average molecular mass of ~120 kDa
corresponding to nine chains similar to the previous
results obtained from wild-type PIDDosome core
complex. However, the minimum average molecular
mass at 1.5 mg/mL concentration was ~104 kDa
corresponding to eight chains and slightly higher
than that observed for the wild-type PIDDosome
core complex.
The purified mutant complex was also subjected to
nanoESI-MS analysis. The mass spectrum again
showed signals corresponding to highm/z ion series
Fig. 8. Assessment of the molecular mass of the RAIDD-DD (E188K):PIDD-DD complex in solution by (a) SEC-MALS
and (b) nanoESI-MS. In (a), the overall protein loading concentration was 1.5 mg/mL (magenta), 12 mg/mL (blue) and
24 mg/mL (red). In (b), mass spectrum of 15 μM complex in 50 mM ammonium acetate buffer (pH 7.8) and ion series
corresponding to the major RAIDD-DD:PIDD-DD species with 5:5 stoichiometry are labeled with charge states, indicated
with blue circles. The presence of a low concentration consistent with 5:4 stoichiometry is indicated (green stars).
745Asymmetry of the PIDDosome Core Complexattributable to the PIDDosome particles. There were
two overlapping charge series of ions. These series
represent assemblies with overall masses of
119 kDa and 132 kDa corresponding to 5:4 and
5:5 RAIDD-DD:PIDD-DD stoichiometric ratios based
on the internal mass references for the isolated
monomers (Fig. 8b). The population distribution for
the two complexes was 13% and 87%, respectively,
and the recovered molecular masses were within 3%
of the predicted values based on the amino acid
sequence.
Taken together, the intact MS data suggest that
the RAIDD-DD (E188K) mutation alters the compo-
sition of the particles formed in combination with
PIDD-DD to yield a dominant species with 5:5
stoichiometric ratio, consistent with the notion that
two RAIDD-DD domains are relatively loosely bound
into the wild-type particle.
Cross-peak splitting and cluster formation is
an indication of asymmetric properties of the
complex
We separately examined the complex formed
between RAIDD-DD (E188K) and PIDD-DD using
15N-HSQC and 13C-methyl-TROSY NMR in the
same way as for the wild type. The results of the
15N-HSQC experiments of the 15N-labeled
RAIDD-DD (E188K) were almost identical withthose of the wild-type RAIDD-DD, consistent with
formation of a high-molecular-weight species for
which the transverse nuclear relaxation rates lead to
loss of signal for all but the most mobile regions of
the component protein domains (data not shown).
The corresponding 13C-methyl-TROSY experiments
results are presented in Fig. 9: (a) and (b) depict the
13C-methyl-TROSY spectra of isolated wild type and
mutant ILV-RAIDD-DD, respectively, and (c) and (d)
show the spectra of the complexes formed in each
case in the presence of excess PIDD-DD. The
principal observation is that, as for the wild-type
case, the behavior of the cross-peaks is divisible into
two classes: a subset remains relatively unperturbed
in chemical shifts and broaden only slightly and a
second subset is transformed into clusters of cross-
peaks with resolved or partially resolved chemical
shifts and much lower intensity. Overall, the pattern
of behavior and the nature of the chemical shift
perturbations for the second subset of cross-peaks
are highly similar to those observed for the wild-type
complex. Figure 9 illustrates that, in spectra of the
wild-type and mutant ILV-RAIDD-DD:PIDD-DD com-
plexes, the effects of complexation are highly similar.
However, careful inspection shows that, despite the
high degree of overlap in the spectrum, it is possible
to identify subtle differences between the cross-peak
clusters in the spectra. An example of these
differences is provided by the RAIDD-DD
Fig. 9. Comparison of the 13C-methyl-TROSY NMR spectra of wild type (a and c) and RAIDD-DD (E188K) (b and d) in
the absence and presence of excess PIDD-DD. The positions of the cross-peaks of unbound RAIDD-DD (E188K) are
essentially identical with those of the wild type. However, notable differences in the cross-peak clusters corresponding to
the well-resolved RAIDD-DD Val189-Cγ2H3 cross-peak (highlighted by red rectangles) are detected, presumably reflecting
both the proximity to the mutation site at residue 188 and the different overall stoichiometry of the complex formed.
746 Asymmetry of the PIDDosome Core ComplexVal189-Cγ2H3 cross-peak highlighted by the red
boxes in Fig. 9. Val189 residue neighbors the
mutation site at position 188, within the α5–α6 loop
with the side chain partially buried in between the
flank of the α5 helix and the N-terminal end of the α6
helix (Fig. 7a). The relative solvent-accessible
surface area for this residue in RAIDD-DD chains
R1 through R7 is 22%, 19%, 24%, 27%, 7%, 13%
and 18%, respectively. The chemical shifts of the
Val189-Cγ2H3 cross-peak are essentially insensi-
tive to the Glu188Lys mutation in the isolated
RAIDD-DD protein—the centers of the two cross--
peaks differ by less than the line widths. However,
on formation of the complex with PIDD-DD, the
pattern of the local cluster of derivative cross-peaks,
close to the chemical shifts of the original Val189
signal, is noticeably different between the case
of wild-type and mutant RAIDD-DD:PIDD-DD
complexes (cf. peak clusters highlighted in Fig. 9c
and d).Discussion
We have described the analysis of the molecular
weight and subunit stoichiometry of the PIDDosome
core particles using SEC-MALS, intact MS and
heteronuclear NMR spectroscopy. Consistent withexpectations from previous work, we found that the
combination of RAIDD-DD and PIDD-DD in solution
leads to the formation of multimeric complexes with
molecular masses above 100 kDa. Our observations
can be described in terms of the formation of Rm:Pn
particles in which R and P correspond to the DDs of
RAIDD and PIDD, respectively, and m and n are
integers corresponding to the numbers of each domain
in the complex. At relatively high protein concentration,
the SEC-MALS results for both wild-type and mutant
Rm:Pn particles using SEC-MALS (Figs. 3a and 8a)
suggest a composition comprising a total of nine
chains for both wild-type andmutant PIDDosome core
complexes. The staining pattern obtained from
SDS-PAGE separation of the complexes indicated
an approximately equal amount of PIDD-DD and
RAIDD-DD molecules in the complex. Coupled with
knowledge of the individual domain masses that differ
by only 0.4 kDa (~3.1%), we would predict quasi-e-
quimolar composition for the particles. On their own,
these results would lead us to conclude that the
particles detected using SEC-MALS analysis corre-
sponds to the formation of either R4:P5 or R5:P4
particles. At lower protein concentration (1.5 mg/mL),
the predicted masses for the eluting complexes are
somewhat lower: 93 kDa for thewild typeand104 kDa
for themutant corresponding to compositions of R4:P3,
R3:P4 or R4:P4, respectively.
747Asymmetry of the PIDDosome Core ComplexWhen the PIDDosome core complexes were
characterized using MS, the data similarly indicated
the potential for flexible stoichiometry. Namely, the
data for the wild-type complex indicate the presence
of species corresponding to R6:P5 (43%), R7:P5
(29%) and R5:P5 (28%) (Fig. 3b). For the mutant
complex, the particles were significantly lighter, and
the sample had a lower degree of compositional
dispersion: R5:P4 (13%) and R5:P5 (87%) (Fig. 8b).
Intriguingly, the masses measured do not corre-
spond precisely to that expected for the R7:P5
complex detected both in crystallo and visualized
by electron microscopy [2].
Taken together, the SEC-MALS and nanoESI-MS
clearly indicate that the PIDDosome core particles
can possess a flexible composition in solution and
that perhaps the particles contain a “stable” core of
seven, eight or as many as ten domains that can be
appended at higher protein concentrations by
additional PIDD-DD and, more likely, RAIDD-DD
domains. In this picture, the R7:P5 complex that can
form into a crystal lattice corresponds to only the
heaviest of a series of different particle types that
can be detected in solution.
The apparent discordance between the SEC-
MALS and the MS measurements presumably
reflects an aspect of the behavior of this type of
system. It has been reported before that the mass of
a binary DD complex appears to be lower by
SEC-MALS than by nanoESI-MS [33]. A confound-
ing aspect of the SEC-MALS measurements might
be that the concentration of the sample effectively
diminishes by diffusional “spreading” as it moves
down the column matrix, making the measurement
technically a non-equilibrium one. Thus, the instan-
taneous concentration of the analyte in the eluant at
the detector is significantly lower than that which was
loaded at the start. For complexes that form with a
high degree of cooperativity or small equilibrium
dissociation constant, such dilution may not greatly
affect the molecular mass measurement. For com-
plexes demonstrating either weak cooperativity or
high dissociation constant, then it is possible that the
SEC-MALS methodology may lead to underestima-
tion of the equilibrium molecular mass.
We adopted specific isotope labeling and hetero-
nuclear NMR spectroscopy to probe the nature of the
PIDDosome core complexes. Both 1H,15N-HSQC
and methyl-TROSY experiments reveal that signals
from the flexible terminal regions of the proteins
remain relatively sharp with no significant chemical
shift perturbations. For the corresponding reso-
nances, the high molecular mass and slow overall
tumbling of the particles does not significantly
contribute to the line width. These resonances are in
the fast exchange regime between the essentially
identical chemical shifts for free and complex states
[33]. On the other hand, the cross-peaks from the
globular regions are either broadened to the noiselevel in the case of the 15N-HSQC measurements or
split into clusters of cross-peaks with evidence for
chemical shift heterogeneity and diminished peak
intensities in the case of the 13C-methyl-TROSY
experiments. The precise nature of the exchange
regime that is operative in the 15N-HSQCexperiments
is not clear since we have been unable to detect the
bound-state signals and thereby identify the chemical
shift differences (Fig. 4). Stepwise addition of
PIDD-DD to 15N-RAIDD-DD or RAIDD-DD to
15N-PIDD-DD leads to systematic diminution of the
intensity of the free-state cross-peaks in the
15N-HSQC spectrum, suggesting that the system
displays slow exchange between the narrow signals
representativeof the 15N-labeledmonomer, aswell as
invisible broad signals of the bound complex. At-
tempts to recover the signals of the bound state using
15N, 2H-labeled proteins and 15N, 1H-TROSY
methods did not yield any further information to
resolve the basis for the appearance of the
15N-HSQC spectra of the complexes.
ILV-labeling strategies [34] and minimization of
transverse relaxation effects for methyl groups using
13C-methyl-TROSY NMR [24,39,40] make it possi-
ble to record high-quality solution NMR spectra of
high-molecular-mass complexes [24,25]. Typically,
application of 13C-methyl-TROSY to appropriately
isotope-labeled proteins yields spectra that exhibit
good sensitivity and resolution, even in instances
where the corresponding 15N,1H-NMR spectra are
intractable. When applied to the PIDDosome core
complex, the resulting spectra are distinctly more
complex that would be expected for a multimeric
system with symmetric quaternary structure. Not
unexpectedly, the methyl groups of Ile, Leu and Val
residues in the N- and C-termini flexible regions yield
essentially unperturbed “singlet” cross-peaks con-
sistent with maintenance of a high degree of disorder
in the complex (Fig. 5). On the other hand, the
spectra clearly suggest that individual methyl groups
within the globular regions of both RAIDD-DD and
PIDD-DD occupy multiple distinct environments
leading to a multiplicity of 1H and 13C chemical
shifts and clusters of resolved or partially resolved
cross-peaks in the 2D NMR spectrum. In principle,
the origin of such complexity could arise either from
the presence of asymmetry in the complex or from
compositional dispersion of the particles in solution.
Having obtained evidence for the compositional
dispersion by SEC-MALS and MS measurements of
the PIDDosome core complex, we sought to
minimize this property by consideration of the crystal
structure. Reflecting on the pattern of B-factors in the
crystal structure that suggested some flexibility or
disorder in the R6 and R7 RAIDD-DD domains,
coupled with the relatively select nature of the type II
contacts between domains R5 and R6, as well as
domains R2 and R7, we probed the effect of
mutating the residue Glu188 in RAIDD-DD. Glu188
748 Asymmetry of the PIDDosome Core Complexin R5 and R2 makes hydrogen bond and electro-
static contact with both Gln169 and Arg170 in R6
and R7, whereas in R1, R3-R4 and R6-R7, Glu188 is
highly exposed to solvent. Therefore, mutation of this
residue was expected to impact only the R5:R6 and
R2:R7 interfaces and leave unchanged all other
types I–III R:R and R:P contacts. Mutation of Glu188
to Lys clearly lowered both the overall molecular
mass and compositional dispersion of the PIDDo-
some particles formed, as assessed by nanoE-
SI-MS. By far, the dominant species in solution
under these conditions is the R5:P5 heterodecamer.
Despite the effects of the RAIDD-DD (E188K)
mutation on the apparent mass of the particle, the
13C-methyl-TROSY NMR spectrum of the mutant
PIDDosome complex is, for the most part, indistin-
guishable from that of the wild-type complex (Fig. 9).
The characteristic cross-peak clusters are still
present. The fact that the overall character of the
spectrum is barely changed argues that its complex-
ity derives from low or absent symmetry of the
complex, as opposed to compositional dispersion.
Moreover, the fact that differences between the
spectra are restricted to cross-peaks whose resi-
dues are close to the mutation site (e.g., Val189;
Fig. 9) is consistent with successful disruption of the
contacts involving the “apical” domains R6 and R7
and that the spectrum of the mutant complex is that
of the R5:P5 “core” We note that, while it is strictly
impossible to conceive of a structure with composi-
tion R7:P5 that possesses overall symmetry, in
principle, a particle with composition R5:P5 could
possess cylindrical symmetry (an R5 ring sitting on a
P5 ring) that would yield degenerate chemical shifts
for any given nucleus. The fact that the spectrum of
the mutant PIDDosome core particle displays
non-degenerate chemical shifts argues that the
structure of the particle in solution is closely similar
to that of the corresponding R5:P5 portion of the
wild-type crystal structure. Close inspection of the
spectrum indicates that each cross-peak cluster
comprises at least four components and the shape of
the individual components sometime hints at a close
overlap of two (or more) (Fig. 7). Thus, it is
conceivable that each cluster comprises at most
five components consistent with the five unique
environments predicted for a R5:P5 particle that lacks
symmetry. For example, in Fig. 6b, it appears that, in
the complexed state, the δ1-methyl-group cross-
peak of PIDD-DD Ile820 forms a cluster of three
features at minimum (with ~2:1:2 peak intensity
ratio) and the corresponding cross-peak of PIDD-DD
Ile832 forms a cluster of four features (with ~2:1:1:1
intensity ratio). In the crystal structure, the Ile820
residue is on the solvent-exposed surface of
domains P2 and P5, and for P1, P3 and P4, it is
involved in type III interactions with P2, P4 and P5,
respectively (schematically represented in Fig. 7b).
Ile832 is involved in type III interactions for all ofP1-P5, in three cases being juxtaposed with Arg815
in the neighboring PIDD-DD domain (P2:P5, P4:P3
and P5:P4 contacts) and in the other two cases
being juxtaposed with Arg147 from a neighboring
RAIDD-DD domain (P1:R5 and P3:R2 contacts)
(Fig. 7b). Given the level of asymmetry, it would be
not unexpected that the cross-peaks corresponding
to individual sites in the structure could display
different chemical shifts. The fact that the cross-peak
clusters comprise multiple subpeaks suggests that
any exchange of protein chains between sites with
the particle is slow on the chemical shift timescale.
We note that the line widths and peak intensities
exhibited within a given cluster and, indeed, across
clusters for a given residue type appear non-uniform.
Notwithstanding the potential for accidental overlap
of cluster components, differential line broadening of
signals in 13C-methyl-TROSY spectra might also
arise due to the precise nature of dipolar interactions
between the protons of a given methyl group with the
“external” protons from other methyl groups (assum-
ing no other proton to be present in the protein chain
or bulk solvent) [41]. In an asymmetric structure,
since the environments of a given residue in the, say,
RAIDD-DD chains, are different (albeit sometimes
subtly) within the overall particle structure, the
potential exists for differential contributions of
1H–1H interactions to the resonance line widths.
Instances of heterogeneity in the NMR spectra of
purified proteins have been reported before but
within rather different contexts to that reported
here. “Trivial” examples of chemical shift non-de-
generacy can occur in the event of conformational
exchange processes such as cis–trans isomeriza-
tion of Xxx-Pro peptide bonds or inversion of the
stereochemistry within disulfide bonds [42,43]. Ho-
modimeric proteins are almost universally observed
to yield a single set of cross-peaks in the NMR
spectrum, consistent with either the formation of a
symmetric homodimer in solution or to the fast
exchange of two asymmetric conformers within a
AB ⇌ BA equilibrium. An example of the latter case
has been reported for the leucine zipper domain of
the DNA-binding protein c-Jun where a pair of
asparagine residues switches between two self-similar
hydrogen bonding arrangements [44]. Amore extreme
case of a AB ⇌ BA equilibrium is presented by the
integral membrane transporter EmrE fromEscherichia
coli prepared in lipid bicelles [45]. In this example, the
exchange is slow on the NMR timescale, and as
a result, each NMR active nucleus in the protein
exhibits two sets of chemical shifts, yielding doubled
cross-peaks in multidimensional NMR data. Evidence
for the exchange between the two structurally identical
structures in the asymmetric dimer is provided in the
form of ZZ-exchange correlations and the pattern of
paramagnetic relaxation enhancement effects induced
in the presence of a water-soluble lanthanide reagent.
More common instances of chemical shift
749Asymmetry of the PIDDosome Core Complexheterogeneity arise due to the effect of symmetry
breaking when a symmetric homomer protein binds to
a single target molecule, such as in the case when the
RNA-binding domain of the bacterial protein LicT (also
known as co-antiterminator, CAT) forms a complex
with the ribonucleic antiterminator (RAT) target [46]. In
isolation, the CAT protein forms a symmetric homodi-
mer with a single set of NMR cross-peaks, whereas
when bound to the RNA partner in a 2(CAT):1(RAT)
complex, the number of features in the protein NMR
spectrum was doubled, reflecting its intrinsic asymme-
try. Analogous behavior was observed for the complex
of the homodimeric Bacillus subtilis replication termi-
nator protein with a 21-base-pair, double-stranded
DNA target [47]. Similarly, it has been reported that
addition of a protein ligands to the homodimeric heat
shock 90 protein leads to peak doubling attributed to
symmetry breaking, evidenced in the methyl-TROSY
spectra [48,49].
AB ⇌ BA equilibria and symmetry breaking do not
appear to be relevant to the PIDDosome core NMR
data. Rather, it would be necessary to appeal to
homomeric systems that display non-equivalent
environments in the separate protomers, such as
n-mers (n greater than 3) that exhibit parallel helical
symmetry. For example, NMR studies of peptides
designed to mimic collagen yield non-degenerate
chemical shifts for equivalent atoms in the leading,
middle and trailing strands [50,51]. To our knowledge,
no instance of an application of 13C-methyl-TROSY
NMR has yet been reported for a system with helical
symmetry. Rather, the closest that such applications
have come to an asymmetric system is the observa-
tion that, in the homoheptameric 20S core particle,
proteasome methionine residues in the N-terminal
region of the α subunits can exchange between
locations inside and outside of the catalytic cham-
ber, characterized by different chemical shifts in the
methyl-TROSY spectrum [52]. On average, only
two of the flexible termini are in the “in” state at
any one time, and thus, the structure is formally
non-symmetric.
Detailed examination on the crystal structure of the
PIDDosome core reveals the presence of pseudo-
helical symmetry [53]. Thus, the authors of the work
describe that the pattern of P-R heterodimeric
“subcomplexes” is arranged in five successive
screw rotations around a central (vertical) axis; the
screw rotations are of two types, one of 84° and
translating down the axis (three occurrences) and the
other one of 54° translating up the axis (two
occurrences) (Fig. 2b). Alternatively, the structure
can be described as a double-stranded left-handed
helical oligomer, where each of the strands contains
both PIDD-DD and RAIDD-DD subunits [53]. De-
spite these elements of pseudosymmetry, one
would still predict from this structure the potential
for non-degenerate chemical shifts for the different
PIDD-DDs and RAIDD-DDs particularly for residuesclose to any of the domain–domain interfaces. Thus,
it seems reasonable to presume that the experimen-
tally observed 13C-methyl-TROSY spectrum reflects
the formation of a structure in solution that is either
identical with or very closely similar to that observed in
the crystal.
The overall pattern of behavior in the NMR spectra
for the PIDDosome core complexes is broadly similar
to that observed for the complex formed betweenDDs
of CD95 and FADD thought to correspond to the core
of the DISC (death-inducing signaling complex) [33].
In the latter case, the data were less clear-cut since
the spectra always contained residual intensity for the
labeled “free” domain, even in the presence of excess
binding partner. Thus, the formation of the PIDDo-
some core complex would appear to have a higher
affinity and a higher degree of cooperativity. Never-
theless, the correspondence of the NMR spectra and
crystal structure of the PIDDosome core reported here
supports the interpretation that theNMRspectra of the
DISC core particle are well explained by a model
based on the crystal structure of the PIDDosome
[33,37] rather than an alternative structure with
discordant molecular mass and other characteris-
tics [54] or on the basis of compositional dispersion.
The NMR spectra of both of these complexes
provide the basis for further investigations into the
mechanism and kinetic aspects of particle assem-
bly using a combination of NMR and intact MS
methods.Experimental ProceduresPlasmid construction and mutagenesis
We use the human PIDD-DD (778–883) and
RAIDD-DD (99–199) corresponding to the DDs,
consistent with those used for the crystal structure
2OF5 [2]. DNA encoding the DD of PIDD and
RAIDD was separately inserted into a pET26b vector
that encodes a non-cleavable C-terminal His6
affinity tag residues. Point mutant RAIDD-DD con-
struct was created using QuikChange site-directed
mutagenesis.
Protein expression, purification and complex
formation
The PIDD-DDs and RAIDD-DDs were expressed
in E. coli BL21(DE3) cells at 20 °C and purified using
metal affinity purification (Ni-IDA) followed by SEC
with final elution into 20 mM Tris–HCl (pH 8.0),
50 mM NaCl, 3 mM NaN3 and 0.5 mM tris(2-carbox-
yethyl)phosphine (TCEP) hydrochloride. The sam-
ples were mixed and incubated at room temperature
for 1 h before subjecting them to SEC using Super-
dex S200 HR 10/30 (GE Healthcare). The complex
750 Asymmetry of the PIDDosome Core Complexwas eluted at 12.5 mL and was concentrated to
24 mg/mL.
Uniform 15N isotope, 13C labeling and 2H labeling




ing of PIDDandRAIDDproteins for ILV 13CH3-TROSY
NMR experiments was performed in 99% D2O
M9 medium containing (2H,12C)-glucose as the
sole carbon source. To introduce methyl labels, we
supplemented the medium with 60 mg/L of
2-keto-3,3-d2-4-
13C-butyrate acid and 100 mg/L of
2-keto-3-methyl-d3-3-d1-4-
13C-butyrate for Ile and
Leu/Val, respectively, 1 h before induction. Proteins
for 13CH3-TROSYNMR experiments were exchanged
into NMR buffer [20 mM Tris–HCl (pH 8.0), 50 mM
NaCl and 0.5 mM TCEP HCl] in D2O.
Multi-angle light scattering
Analytical SEC-coupled MALS was recorded at 16
angles using a DAWN-HELEOS laser photometer
(Wyatt Technology) and differential refractometer
(Optilab rEX, Wyatt Technology). Flow cell was
maintained at 25 °C (Wyatt Technology). Complexes
were isolated by semi-preparative S200 size-exclu-
sion column and concentrated in buffer A. Samples
(100 μL)were injected onto aSuperdex 200HR10/30
size-exclusion column (GE Healthcare) equilibrated
buffer containing 20 mM Tris–HCl (pH 8.0), 50 mM
NaCl, 3 mM NaN3 and 0.5 mM TCEP. The flow rate
was 0.5 mL/min. Data were collected and analyzed
using the program ASTRA 5.1 as previously de-
scribed (Ivins et al., 2009).
Intact MS
NanoESI-MS measurements were performed in
the positive ion mode on a modified Q-ToF II mass
spectrometer (Waters) [55], using in-house pre-
pared, gold-coated glass capillaries [47]. The MS
parameters in order to preserve non-covalent inter-
actions were as follows: capillary voltage, 1.5 kV;
cone voltage, 80 V; extractor, 5 V; source backing
pressure, 6–8 mbar; collision cell pressure, 5 psi.
Collision cell energy was between 60 and 100 V.
Me a s u r emen t s w e r e t a k e n f o r i n t a c t
protein complexes prepared for SEC-MALS ana-
lysis and exchanged into 50 mM ammonium acetate
(pH 7.8) using Biospin 6 microspin columns
(Bio-Rad Laboratories). Data were processed
using our in-house software Massign [50]. The
results are representative of multiple independent
experiments.
NMR spectroscopy
All spectra were recorded at 25 °C on Varian
INOVA or Bruker AVANCE spectrometers operatingat 14.1 T, 16.5 T and 18.8 T. Data were processed
with NMRPipe/NMRDRAW (Delaglio, 1995) and
analyzed with CCPN software (Vranken et al.,
2005). Resonance assignments for PIDD and
RAIDD proteins were obtained using standard
protocols. Titrations of a labeled protein (0.2 mM)
with its unlabeled partner (0–1 molar equivalents)
were conducted at constant concentration of the
labeled component (McAlister et al., 1996). Typical
acquisition time for 2D WATERGATE-flipback
15N,1H-HSQC (Grzesiek and Bax, 1993) and
13CH3-TROSY [39] data sets was about 1 h and 3 h,
respectively. Relaxation delay for 13CH3-TROSY
experiments was 1.3 s.
Solvent-accessible surface calculations
Relative side-chain solvent-accessible surface
calculations were performed using NACCESS (Hub-
bard SJ and Thornton JM, 1993), Computer Pro-
gram, Department of Biochemistry and Molecular
Biology, University College London).Acknowledgements
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CARD, caspase recruitment domain; DD, death domain;
nanoESI, nanoflow electrospray ionization; MS, mass
spectrometry; HSQC, heteronuclear single quantum
coherence; SEC, size-exclusion chromatography; MALS,
multi-angle light scattering; TCEP, tris(2-carboxyethyl)
phosphine; TROSY, transverse relaxation optimized
spectroscopy; 2D, two-dimensional.
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